Comprehensive Analysis of the CRISPR-Based Diagnostics Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the crispr-based diagnostics market grown in recent years?
The market size for diagnostics based on CRISPR technology has seen swift expansion in the past few years. The market, which is set to increase from $4.35 billion in 2024 to $5.14 billion in 2025, is expected to experience a compound annual growth rate (CAGR) of 18.1%. This profound growth during the historic period can be linked to factors such as an increase in health care spending, a surge in demand for gene editing, a rise in the occurrence of chronic diseases, heightened awareness about treatment options, and an uptick in the rate of genetic diseases.
How is the crispr-based diagnostics market size expected to evolve during the forecast period?
The market size of CRISPR-based diagnostics is predicted to experience a significant surge in the coming years, expanding to $9.92 billion by 2029 at a compound annual growth rate (CAGR) of 17.9%. This substantial growth in the forecast period can be linked to factors such as increasing need for rapid and precise diagnostic tools, expanding use in detecting infectious diseases, government and institutional financial support, better identification of antibiotic resistance, as well as the expanding awareness and acceptance of CRISPR technologies. The projection period will also see major trends like point-of-care (POC) testing, CRISPR-Cas12 and Cas13 systems, personalized medicine and genetic screening, merging with nanotechnology and biosensors, and early disease detection utilizing CRISPR technology.
Get your crispr-based diagnostics market report here!
https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report
Which key drivers are propelling the crispr-based diagnostics market’s growth?
The anticipated expansion of the CRISPR-based diagnostics market is largely due to the growing prevalence of infectious diseases. Pathogenic microorganisms such as viruses, bacteria, fungi, or parasites are responsible for these diseases, which can transmit through direct or indirect human contact, contaminated objects, food, water, or insect vectors. Several factors like globalization, antibiotic resistance, climatic alterations, urbanization, population surge, habitat destruction, and lack of proper healthcare contribute to the increase in infectious diseases. CRISPR-based diagnostics advance the battle against these diseases by offering prompt and precise pathogen identification, allowing for early detection, timely response, and efficient control measures. For example, the UK Health Security Agency released data in August 2024, showing that the number of measles cases in England surged to 368 in 2023 from 53 in 2022, a nearly sevenfold increase. The West Midlands and London accounted for 44% and 33% of these cases, respectively. Consequently, the escalating prevalence of infectious diseases is a significant driver for the growth of the CRISPR-based diagnostics market.
What are the market segments in the crispr-based diagnostics industry?
The CRISPR-based diagnostics market covered in this report is segmented –
1) By Product: Kits, Buffer Solutions, Software, Other Products
2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-mediated Isothermal Amplification (LAMP), Other Techniques
3) By Disease: Infectious Diseases, Non-Infectious Diseases
4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits
2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers
3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software
4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp
Which leading companies are shaping the growth of the crispr-based diagnostics market?
Major companies operating in the CRISPR-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc.
What are the key trends shaping the future of the crispr-based diagnostics market?
Major companies operating in the CRISPR-based diagnostics market are focusing on developing strategic partnerships to enhance accessibility to rapid and accurate diagnostics through CRISPR-based point-of-care tests. A strategic partnership is a long-term collaboration between two or more organizations that share resources and expertise to achieve mutual goals and enhance their competitive advantage. For instance, in August 2023, CrisprBits Private Limited, an India-based biotechnology company, announced a strategic collaboration with Molbio Diagnostics, an India-based molecular diagnostics company, to develop CRISPR-based Point-of-Care Tests (POCTs). This collaboration focuses on creating rapid, precise, and cost-effective diagnostic tools leveraging CRISPR technology for detecting pathogens and genetic markers. These POCTs aim to enhance diagnostic accessibility in diverse settings, including resource-limited areas, while ensuring swift and accurate disease detection. The partnership combines CrisprBits’ expertise in CRISPR-based platforms with Molbio’s manufacturing and distribution capabilities to bring these tests to a global market.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20734
Which geographic areas are influencing the growth of the crispr-based diagnostics market?
North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR-based diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Medical And Diagnostic Laboratory Services Global Market Report 2025
Diagnostic Equipment Global Market Report 2025
https://thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report
Global Anesthesia And Respiratory Devices Opportunities And Strategies Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
